Philippe Clavel
Chief Executive Officer bei Curapath & Expansion of Drug Delivery Capabilities & Services
Profil
Philippe Clavel is currently the Chief Executive Officer at Curapath & Expansion of Drug Delivery Capabilities & Services.
He is also a Member-Supervisory Board at Réseau de Transport d'Electricité SA. Previously, he was the Chief Executive Officer at PCAS SA from 2021 to 2022, and Vice President at Seqens International SASU from 2020 to 2023.
He holds a doctorate degree from Université de Bordeaux and a graduate degree from École Nationale Supérieure de Chimie de Paris.
Aktive Positionen von Philippe Clavel
| Unternehmen | Position | Beginn |
|---|---|---|
Réseau de Transport d'Electricité SA
 Réseau de Transport d'Electricité SA Electric UtilitiesUtilities Réseau de Transport d'Electricité SA maintains and develops the French electricity transmission network. The company was founded in 2000 and is headquartered in Paris, France. | Director/Board Member | - |
Curapath & Expansion of Drug Delivery Capabilities & Services
 Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Chief Executive Officer | 13.12.2023 |
Ehemalige bekannte Positionen von Philippe Clavel
| Unternehmen | Position | Ende |
|---|---|---|
Seqens International SASU
 Seqens International SASU Financial ConglomeratesFinance Seqens International SASU functions as an investment holding French company. The private company is based in Écully, France. | Private Equity Investor | 01.02.2023 |
Seqens International SASU
Seqens International SASU Financial ConglomeratesFinance Seqens International SASU functions as an investment holding French company. The private company is based in Écully, France. | Private Equity Investor | 01.02.2023 |
| PCAS | Chief Executive Officer | 28.11.2022 |
Ausbildung von Philippe Clavel
| Université de Bordeaux | Doctorate Degree |
| École Nationale Supérieure de Chimie de Paris | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PCAS | Process Industries |
| Private Unternehmen | 3 |
|---|---|
Réseau de Transport d'Electricité SA
Réseau de Transport d'Electricité SA Electric UtilitiesUtilities Réseau de Transport d'Electricité SA maintains and develops the French electricity transmission network. The company was founded in 2000 and is headquartered in Paris, France. | Utilities |
Curapath & Expansion of Drug Delivery Capabilities & Services
Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Health Technology |
Seqens International SASU
Seqens International SASU Financial ConglomeratesFinance Seqens International SASU functions as an investment holding French company. The private company is based in Écully, France. | Finance |
